Arsenal Medical
Watertown
About Arsenal Medical
Arsenal Medical uses conventional biomaterials in unconventional ways to develop novel products that improve local therapy for injury and disease. The company is advancing multiple preclinical programs based on both its two proprietary technology platforms: its therapeutic foam and AxioCore, a novel, high-throughput nanofiber technology. Arsenal Medical is supported by venture funding, as well as grants from the Department of Defense, National Institute of Standards and Technology’s Technology Innovation Program (NIST-TIP), and the Bill & Melinda Gates Foundation. Its investors include Polaris Venture Partners, North Bridge Venture Partners, and Intersouth Partners.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $69.4M
- Last round: Non-Equity Assistance (May 2024)
- Website: arsenalmedical.com
- Phone: 781-755-8100
Industries & Categories
Biotechnology, Health Care, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/arsenal-medical-54404 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.